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Monkeypox	virus	is	a	zoonotic	virus	endemic	to	Central	
Africa. Although active disease surveillance has assessed 
monkeypox	disease	prevalence	and	geographic	range,	in-
formation	about	virus	diversity	is	lacking.	We	therefore	as-
sessed	genome	diversity	of	viruses	in	60	samples	obtained	
from humans with primary and secondary cases of infection 
from	2005	 through	2007.	We	detected	4	distinct	 lineages	
and	a	deletion	that	resulted	in	gene	loss	in	10	(16.7%)	sam-
ples and that seemed to correlate with human-to-human 
transmission	(p	=	0.0544).	The	data	suggest	a	high	frequen-
cy of spillover events from the pool of viruses in nonhuman 
animals, active selection through genomic destabilization 
and gene loss, and increased disease transmissibility and 
severity. The potential for accelerated adaptation to humans 
should be monitored through improved surveillance.
Viruses in the family Poxviridae, genus Orthopoxvi-rus, consist of numerous pathogens known to infect 
humans, including variola virus (VARV), monkeypox vi-
rus (MPXV), cowpox virus (CPXV), and vaccinia virus 
(VACV). Genomes of these viruses are ≈200 kb long, have 
highly conserved central regions coding for replication and 
assembly machinery, and have more variable terminal ends 
that contain genes involved in host range determination and 
pathogenesis (1).
Although orthopoxviruses are antigenically and ge-
netically similar, they have diverse host range and viru-
lence properties (1–6). Comparative genomics studies have 
shown that the evolution of orthopoxviruses is ongoing 
and can be driven by selective pressure from a host species 
(4,7). It has been postulated that progressive gene loss, pri-
marily at the terminal ends of the genome, has been a driv-
ing force behind the evolution of these viruses (7). CPXV, 
which causes only mild infection in humans, contains the 
largest genome of all sequenced orthopoxviruses (≈220 
kb), encodes 223 open reading frames (ORFs), and has a 
broad host range that includes rodents, humans, felids, bo-
vids, and voles (7–10). Conversely, VARV, the causative 
agent of smallpox, is highly pathogenic (case-fatality rate 
≈30%) (11), has the smallest genome of all naturally occur-
ring orthopoxviruses (≈186 kb), is predicted to encode 20% 
fewer functional proteins than CPXV, and has a host range 
restricted to humans (7).
Similar to VARV, MPXV is a virulent orthopoxvirus 
that causes high levels of illness and death (case-fatality 
rate ≈10%) (12–15). Unlike natural VARV infections, 
which were declared eradicated in 1979, MPXV infec-
tions occur naturally in MPXV-endemic regions of Africa, 
such as the Democratic Republic of the Congo (DRC) and 
Republic of the Congo. Human exposure to animal reser-
voirs, including squirrels of the genera Funisciurus and 
Heliosciurus, poses high risk for MPXV infection (16–19). 
Recent reports suggest that human-to-human transmission 
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of MPXV is increasing (20,21). In 2003 in the DRC, 7 
generations of uninterrupted spread among humans were 
reported (21). Increasing susceptibility coincident with de-
creasing herd immunity is expected to profoundly increase 
the introduction and spread of MPXV among humans. In 
2003, an outbreak of monkeypox in the midwestern United 
States revealed the propensity for transmission to MPXV-
naive populations (22). The strain of MPXV responsible 
belonged to the Western African clade; these strains tend 
to be less pathogenic than the Central African strains that 
circulate in the DRC (2).
MPXV is a linear DNA genome of ≈197 kb and con-
tains ≈190 nonoverlapping ORFs >180 nt long (1,7,26). 
Like all orthopoxviruses, the central coding region sequence 
(CRS) at MPXV nucleotide positions ≈56000–120000 is 
highly conserved and flanked by variable ends that contain 
inverted terminal repeats (ITRs) (1). VACV homologs to 
genes found in the terminal ends of the MPXV genome are 
predominantly involved in immunomodulation, and most 
are either predicted or known to influence host range de-
termination and pathogenicity (27). Unlike VARV, which 
lacks ORFs in the ITR region, MPXV contains at least 4 
ORFs in the ITR region (7,26).
The evolution of short-read, high-throughput sequenc-
ing technologies has made genomic surveys of large pop-
ulations readily attainable (23,24). It has been suggested 
that the progressive loss of genes that were not essential 
for pathogenesis in humans is the mechanism that led to 
the emergence of a highly adapted virus that causes seri-
ous disease and is capable of efficient and rapid human-to-
human transmission (7). A recent study demonstrated that 
gene copy number variation might be a crucial factor for 
modulating virus fitness (25). In the study reported here, we 
investigated the genomic plasticity of MPXV strains ob-
tained from patients in the DRC during active surveillance 
for monkeypox disease (20).
Materials and Methods
Sample Selection
 From November 2005 through November 2007, a total 
of 760 cases of human monkeypox in the Sankuru District, 
DRC, were identified by active disease surveillance and con-
firmed by quantitative real-time PCR (20). From these, we 
selected 60 cases on the basis of 3 epidemiologic measures: 
severity, transmission, and geography. The samples chosen 
represented the entire set of samples and included samples 
from every category of severity and transmission observed 
and every geographic location sampled. Of the 60 cases, we 
sequenced 29 representative scab or vesicle fluid samples 
from patients whose samples met the criteria for concen-
tration and quality of genetic material (>500 ng total DNA 
and >1.8 260/230 and 260/280 absorbance ratio). We used 
the Genome Analyzer IIx and MiSeq sequencers (Illumina, 
Inc., San Diego, CA, USA) to conduct 76-bp or 100-bp, 
paired-end sequencing. To avoid laboratory-induced muta-
tion events, we sequenced these samples directly from scab 
or vesicle material without virus isolation or propagation.
Sample Collection and Processing
 Techniques for sample collection, processing, nucle-
otide isolation, and real-time PCR have been described 
(20,28,29). The World Health Organization scoring system 
used during the smallpox eradication program was used 
to generate severity designations: presence of <25 lesions 
on the body was considered mild disease; 25–99 lesions, 
moderate; 100–250 lesions, severe, and >250 lesions, seri-
ous. Libraries with an average insert size of ≈300 bp were 
processed by using the TruSeq (Illumina, Inc.) sequencing 
kit version 5 and sequenced for either 76 or 100 cycles 
from each end on an Illumina Genome Analyzer IIx or 
MiSeq instrument.
Genome Assembly
 All raw Illumina sequence data were processed 
through an in-house–developed filtering program that re-
moves or trims reads with known artifacts. Specifically, all 
reads containing adaptor sequence, low-complexity reads, 
or PCR duplicates were removed or trimmed. Host read 
exclusion was performed by removing reads that aligned 
to the human genome (Homo sapiens chromosome 10, 
GRCh37 primary reference assembly) by using the CASA-
VA pipeline 1.8 (Illumina, Inc.) with default parameters. 
De novo assemblies were performed by using SeqMan Pro 
NGen (DNAStar, Inc., Madison, WI, USA) with default 
parameters. Genome size was set to 200 kb. The optimal 
k-mer was determined by using an iterative assembly pro-
cess. We closed gaps in coverage and resolved large repeats 
by using Sanger sequencing for the 23 genomes described 
in this work. Sequences were submitted to GenBank with 
accession nos. JX878407–JX878429.
Phylogenetic Analysis
 We conducted the phylogenetic analysis by using 
methods identical to those reported for VARV diversity 
(4). In brief, we aligned the CRS (MPXV nucleotide posi-
tions ≈56000 120000) of samples with sufficient sequence 
information with 11 MXPV reference sequences available 
through the National Center for Biotechnology Informa-
tion (www.ncbi.nlm.nih.gov/), GenBank nos. KC257459, 
KC257460, DQ011154, DQ011155, HQ857562, 
HQ857563, NC_003310, AY603973, AY753185, 
AY741551, DQ011156, DQ011153, and DQ011157 in Se-
qMan Pro NGen (DNAStar, Inc.). Manual editing of gaps 
and ambiguous base calls of the alignment were performed 
to include the draft genomes and provide a more robust 
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phylogenetic narrative. The resulting alignment was ana-
lyzed by using Bayesian methods of phylogenetic recon-
struction and the GTR+Γ evolutionary model. MrBayes 
version 3.1.2 (30) was run by using 1,000,000 generations 
with 4 parallel runs. Markov chain Monte Carlo conver-
gence was assessed by checking the average standard de-
viation of split frequencies (<0.01) during >10,000 genera-
tions. Figure 1 shows the unrooted tree based on alignment 
of the 11 MPXV reference sequences and the viral ge-
nomes from the 23 clinical samples in this study. 
PCR Screening 
 All primers were developed by using Primer-BLAST 
(www.ncbi.nlm.nih.gov/tools/primer-blast/) with default 
parameters. This software uses Primer3 to design the prim-
ers and then BLAST to determine specificity. We designed 
qualitative PCRs to detect the left and right short tandem 
repeats (STRs) at MPXV nucleotide positions 72–486 and 
196710–197124, a region spanning the 625-bp deletion 
between bases 189820 and 190444 in the right ITR, and a 
410-bp region of the CRS that contains 4 single-nucleotide 
polymorphism locations positively typing the lineages de-
scribed in this article between nucleotide positions 89273 
and 89944. All PCRs were run by using standard methods 
and optimized annealing temperatures of 55°C through 
65°C. The PCR product Sanger sequences were aligned to 
the reference in SeqMan Pro software (DNAStar) for vali-
dation by using default parameters. Primer sequences are 
available on request.
Results
 Referenced and de novo alignments were performed 
by using SeqMan Pro NGen to determine the scaffold of 
the viral genome. Genomes were finished by using PCR 
and traditional dideoxynucleotide sequencing (Sanger) to 
resolve gaps and repetitive and low coverage areas. We ob-
tained 23 MPXV genomes, expanding the available com-
pleted genomes for Central African clade MPXV strains 
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Figure	 1.	 Phylogenetic	 analysis	 of	 whole-genome	 direct	 sequencing.	 Evolutionary	 relationships	 between	 sequenced	 samples	 and	
archived	monkeypox	 virus	 (MPXV)	 sequences	were	 determined	 for	 the	 central	 coding	 region	 sequence	 (MPXV	nucleotide	 positions	
≈56000–120000).	A	cladogram	 representing	 the	 topology	of	an	unrooted	Bayesian	phylogenetic	 reconstruction	 is	shown	 for	samples	
identified	by	sample	number	and/or	GenBank	accession	number.	The	Central	and	Western	African	clades	and	the	4	distinct	 lineages	
are	indicated.	Confidence	values	for	branching	events	were	computed	by	Markov	chain	Monte	Carlo	convergence.	Numbers	at	nodes	
represent	Bayesian	posterior	probabilities	computed	by	using	MrBayes	3.1.2	(30).
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by ≈6-fold. To assess the potential genomic diversity of 
MPXV strains circulating in the DRC, we performed a 
phylogenetic analysis of the CRS. The resulting cladogram 
suggested the emergence of 4 distinct lineages within the 
Central African clade.
Genomic Reduction
 Among the MPXV alignments, we detected a poly-
morphism in the noncoding region of the ITR with 12 vari-
ants. Of the 23 (17.4%) complete genome sequences, 4 
showed substantial genomic instability directly upstream 
of the right ITR. This subset of samples contained a 625-
bp deletion between bases 189820 and 190444 (genome 
positions based on MPXV-COG_2003_358). This dele-
tion completely removes MPV-Z-N2R and eliminates the 
first 103 bp of the orthopoxvirus major histocompatibility 
complex class I–like protein (OMCP, MPV-Z-N3R) (Fig-
ure 2, panel A). The function of the protein expressed from 
MPV-Z-N2R is unknown, and no homologous gene is in 
the VARV or West African MPXV genomes. OMCP is a 
secreted protein that binds to NKG2D and interferes with 
NKG2D-mediated cell killing by natural killer cells (31). A 
conventional PCR created to characterize the deletion en-
abled us to detect this deletion in 6 additional genomes (on-
line Table, wwwnc.cdc.gov/EID/article/20/2/13-0118-T1.
htm.) We found no evidence of a mixed population within 
the sequence information for the isolates containing the de-
letion or in the gel electrophoresis of the Amplicon Sanger 
sequencing products for samples tested (data not shown).
This genetic polymorphism was absent from all 
MPXV sequences available through GenBank. Moreover, 
although 1 full-length copy and 1 truncated copy of the 
OMCP gene are present in all genomes of the Western Af-
rican clade MPXV, only the full-length copy of the gene 
is present in genomes of the Central African MPXV clade 
(Figure 2, panel A). No homologous gene is present in the 
VARV genome (26) (www.poxvirus.org). The deletion 
identified in our clinical samples completely removes the 
region of OMCP containing the leader sequence (Figure 2, 
panel B) and substantially alters protein folding (data not 
shown), suggesting that the truncated protein is nonfunc-
tional. The deletion was identified in genomes belonging 
to lineage B only (online Table). Data regarding route of 
infection were available for 44 patients; transmission for 
24 cases was classified as human-to-human (secondary) 
and for 20 as animal-to-human (primary) (online Table). 
Metadata were available for 8 of the samples containing 
the deletion; 7 (87.5%) of the 8 were from cases resulting 
from human-to-human transmission (p = 0.0544, Fisher ex-
act test), suggesting that this deletion might be associated 
with increased fitness in humans. Further work, however, 
is needed to elucidate the role of OMCP in transmissibility.
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Figure	2.	Truncation	of	OMCP.	A)	Whole-genome	deep	sequencing	revealed	a	625-bp	deletion	directly	upstream	of	the	right	ITR	(red	
box),	which	completely	removed	MPV-Z-N2R	(locus	201)	and	truncated	OMCP	(MPV-Z-N3R,	locus	202).	A	Western	African	clade	virus,	
MPXV-USA_2003_039,	is	shown	for	comparison	with	OMCP	and	N2R	copy	number.	PCR	amplification	regions	for	the	large	deletion	and	
the	STRs	(right	and	left)	are	indicated	by	the	blue	bar	below	each	ITR	diagram.	The	yellow	box	represents	the	ITR	region,	and	all	open	
reading	frames	are	identified	by	their	MPXV-COG_2003_358	locus	number	with	genes	of	interest	in	parenthesis.	B)	Nucleotide	alignment	
of	the	large	deletion	with	MPXV-COG_2003_358	reference	sequence.	The	truncated	protein	created	by	the	deletion	is	indicated	by	the	
black	background.	ITR,	inverted	terminal	repeat;	MPXV,	monkeypox	virus;	COG,	Congo;	STR,	short	terminal	repeat;	OMCP,	orthopoxvirus	
major	histocompatibility	complex	class	I–like	protein.
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STR Analysis
 Substantial variations from other orthopoxviruses 
were detected in the 70-bp STR region (bases 72–486 and 
196710–197124 in MPXV-COG_2003_358) (4,32–34). A 
traditional PCR designed against the left and right STR re-
gions enabled us to evaluate this polymorphism in all 60 
samples. We did not quantitatively test the purity of the 
repeat population beyond visualization of the PCR product 
by gel electrophoresis. A small percentage of the samples 
(10%) had faint secondary products that could not be re-
solved. The STRs described here should be considered 
to be the dominant population. In total, we identified 12 
unique STR combinations (online Table). STR variations 
have been described for VARV isolates obtained during 
1944–1974 (34); however, no studies have addressed the 
possibility of STR variations in VARV isolates belonging 
to the same geographic cluster. Samples collected during 
episodes of VARV activity in Bangladesh, South Africa, 
or the Far East showed limited variation (<3 left STR pat-
terns); whereas, we observed 12 patterns for MPXV sam-
ples collected during a 2-year period in the DRC. Given 
that the poxvirus genomes in our study were character-
ized directly from clinical samples, it is plausible that this 
smaller range of diversity for VARV is only the result of a 
genetic bottleneck that occurred during cell culture isola-
tion. Rapid copy number variation of the K3L gene in the 
VACV ITR has recently been described as a mechanism 
for host immunomodulation (25). However, none of the 
STR copy number variations observed among the MPXV 
strains involved a known coding region. In contrast to some 
VARV isolates, all 60 MPXV samples had identical right 
and left STRs (online Table).
Phylogenetic Analysis of the Entire Dataset
 Because only 23 samples contained enough material 
for complete genome characterization, to expand our anal-
ysis to all 60 samples, we performed PCR amplification 
of a 410-bp variable region of the CRS corresponding to 
the H4L gene (VACV-COP gene notation). When select-
ing this region, we used the phylogenetic relationships of 
the CRS regions of the Central African clade by using 72 
segregating sites over 61 kb of sequence. The selected re-
gion contained 4 segregating sites that are phylogenetically 
relevant to Central African clade MPXV (MPXV acces-
sion no. DQ01154: 89505, 89545, 89674, and 89914). No 
evidence of additional diversity was detected at these sites 
among the samples from the DRC except at the fourth site 
(89914) and only among the members of lineage B. Phy-
logenetic reconstruction of this region among the samples 
resulted in a topologic distribution for DRC isolates that 
correlates with the whole-genome tree (bootstrap values, 
as a measure for confidence measures, were lineage A (n = 
12, 82%), lineage B (n = 11, 81%), lineage C (n = 6, 80%), 
and lineage D (n = 1). Moreover, this region contains 7 
sites that differentiate between the Central African (n = 29) 
and Western African (n = 6) clades with a bootstrap value 
of 82%, which can be evaluated as another measure of the 
phylogenetically informative character of this genomic 
area. In this region, we identified 1 nonsynonymous and 
3 synonymous changes. An additional nonsynonymous 
change was identified in all lineages ≈800 bp downstream 
of this region, for a total of 5 polymorphic sites in H4L 
within the Central African clade.
Overall, 11.6% of the genetic variations identified in 
this study were located in an ≈1.2-kb conserved region of 
the CRS. H4L is reported to be tightly associated with the 
DNA-dependent RNA polymerase, aiding in early gene 
transcription before initiation and termination (35,36). In-
creased mutation rates in a tightly constrained area of a ge-
nome can be a marker of increased selective pressure. The 
effect of the genetic polymorphisms on the function of H4L 
is unknown, and further studies to evaluate their effects on 
early gene expression are needed.
The phylogenetically informative single-nucleotide 
polymorphisms were assessed by PCR amplification and 
dideoxynucleotide sequencing for all 60 samples. This in-
formation was then used to extrapolate the lineage of each 
sample (online Table). 
Lineage A contains the widest range of STR repeats 
(1–15) and represents 33 (55.0%) of the samples analyzed. 
The lineage seems to have arisen in the Lomela health zone 
(forest) where it continued to circulate throughout 2007. 
The remaining members of the lineage are a cluster of 
strains with 13–15 STR repeats that were geographically 
restricted to the Vangakete health zone (savannah). Ac-
cording to the World Health Organization scoring system 
for severity used during smallpox eradication, the virus 
strains belonging to lineage A caused predominantly mod-
erate disease (66.7%, p = 0.2816). No significant differ-
ences in animal-acquired versus human-acquired infection 
were associated with this lineage.
Lineage B contains 1–8 STRs and represents 16 
(26.7%) of the samples analyzed. These strains were pre-
dominantly isolated from the Kole (forest) and Lomela 
health zones and were associated with moderate disease 
(80.0%, p = 0.2179). Although no statistically significant 
association with secondary (human) transmission was 
observed among all lineage B strains, the MPV-Z-N2R/
OMCP deletion was identified only in genomes belonging 
to this lineage and, as stated above, was significantly as-
sociated with human-to-human transmission.
Lineage C showed high homogeneity with only 1 STR 
and represented 10 (6.7%) of the samples analyzed. These 
strains were predominantly obtained from the Djalo-Ndje-
ka (ecotone) and Vangakete health zones and were associ-
ated with severe/serious disease (70.0%, p = 0.0234).
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Only 1 representative of lineage D was identified and 
contained 10 STRs. The sample was collected in Bene Di-
bele (forest), was associated with severe disease, and was 
acquired from a human source.
Although the data do not support causality linking the 
number of STR repeats to the severity of any lineage, the 
composition of the STR region merits further investigation 
for effects on virulence and transmission and as a marker of 
passaging effects. Our data support a wide diversity of STR 
composition that varies according to lineage; 1 population 
exhibited only a dominating single STR repeat and others 
had variants between 1 and 15 repeats. On the basis of our 
data and the information previously reported (25) depicting 
an accordion-like expansion of gene-copy in response to 
antiviral systems, there is precedence for a copy number 
variation mechanism used by the virus. Considering that 
there is no coding element in this region, the most likely 
need to vary this region is structural; therefore, we predict 
that the STR region may be under selective pressure to pro-
vide stability to this region of the genome.
Discussion
Our data demonstrate that a combination of genomic 
destabilization and genetic polymorphism are influencing 
the evolution of MPXV strains actively circulating in the 
Sankuru District of the DRC. Patterns of genomic desta-
bilization and gene loss were consistent with models of 
orthopoxvirus genomic evolution (7). A recently submit-
ted genomic sequence derived from 2 isolates obtained in 
Sudan in 2005 contains a large indel in the right flanking 
region. This indel simultaneously inserts a 10.8-kb invert-
ed repeat of several immune modulatory coding regions 
from the left flanking region and deletes a 2.1-kb region 
that surrounds the region that we identified as reduced. 
The authors who reported the sequence posit that this in-
sertion and deletion resulted from a single event, and the 
identifying sequence is the only evidence of either the in-
sertion or the exact deletion in any Poxviridae isolate (37). 
The 2 reported changes cannot be functionally compared 
in this study; however, additional evidence supports ge-
netic variability in this region. Genomic reduction might 
have played a role in the emergence of VARV as a highly 
adapted human pathogen capable of efficient human-to-
human spread (7). Although it has been suggested that 
gene loss was associated with a restricted host range for 
VARV, no link has been demonstrated between gene loss 
and increased severity of disease. VARV is thought to 
have diverged from its rodent-borne ancestor 3,000–4,000 
years ago (38). The strains of VARV isolated during peri-
ods of high activity in the 20th century were already well 
adapted to their evolutionary niche (humans), and, as a re-
sult, their genetic sequences were highly conserved. Con-
versely, the level of variability for MPXV isolates might 
suggest an active pattern of change; however, longer-term 
surveillance is required.
Although genomic changes are predicted by models 
of host transition, the correlation of the gene loss pattern 
with secondary transmission might indicate that MPXV is 
adapting for efficient replication in a novel ecologic niche: 
humans. It is also plausible that the association of OMCP 
gene loss and transmissibility is coincidental because nu-
merous factors, including vaccination status and human 
encroachment on reservoir habitats, could also explain in-
creased human-to-human transmission and variant intro-
duction frequency. The scarcity of information regarding 
historical orthopoxvirus emergence and the absence of se-
quencing data for MPXV reservoir isolates precludes our 
ability to pinpoint the exact source of the observed vari-
ability; however, we predict that the 4 lineages are circu-
lating in the reservoir population and are introduced into 
the human population after direct contact with those res-
ervoir hosts. Further genomic surveillance that includes 
reservoir species might help explain the variant emergence 
described herein.
Active surveillance during November 2005–Novem-
ber 2007 in Sankuru District, DRC, suggested a strong cor-
relation between smallpox vaccination and protection from 
MPXV (20). However, as the number of unvaccinated per-
sons continues to increase, so does the size of the suscep-
tible population. Other factors in the DRC, such as malnu-
trition, disease, and an inadequate health care system, have 
provided an ideal environment for MPXV. It is possible that 
increased circulation of MPXV in the human population of 
the DRC is a driving force in the evolution of the virus. Our 
data also indicate that certain genetic changes might affect 
disease severity or human-to-human transmissibility, sug-
gesting an active period of adaptation that could result in 
virus strains with increased fitness in humans. However, 
we have no evidence to directly link the genetic changes to 
increased severity or transmissibility in vivo.
The global effects of the emergence of MPXV strains 
that are highly adapted to humans could be devastating. 
Importation of MPXV by infected vertebrates is of con-
cern because of the potential for establishment of new 
reservoirs outside Africa. In fact, American ground squir-
rels have been found to be susceptible to infection (39), 
suggesting that other rodent species worldwide might 
also be susceptible. Small genetic changes could favor 
adaptation to a human host, and this potential is greatest 
for pathogens with moderate transmission rates (such as 
MPXV) (40). The ability to spread rapidly and efficiently 
from human to human could enhance spread by travel-
ers to new regions. Therefore, active disease surveillance 
should continue to be used monitor MPXV for changes 
that are consistent with increasing adaptation to humans. 
Continued active surveillance of the Sankuru District, and 
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expansion to all other regions where the virus is known or 
predicted to circulate, would help determine the true geo-
graphic range of this virus. Given the apparent rapid evo-
lution of this virus, when suspected or confirmed cases in 
humans are observed, health authorities in presently unaf-
fected areas should become vigilant and actively prepare 
to take immediate action.
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